Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2003
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042164A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042160A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003WO2003042147A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/22/2003WO2003041728A1 Novel phenyl-propargylether derivatives
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003WO2002097116A3 Delivery system for nucleic acids
05/22/2003US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
05/22/2003US20030096991 Reacting 2-sulfonamido, nitrobenzoic acid compound with in the presence of a halogenating agent, with formation of the carbonyl halide and its rearrangement; ammonolysis at SO2Cl group reducing at the nitro group; reacting with carbamate
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096715 Lubricant composition, method for using and preparing thereof and molecular complex compound used for the same
05/22/2003US20030096374 Synthesis of oligoketides
05/22/2003US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc.
05/22/2003CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1312607A1 Dithiocarbamate derivatives and their use as antibacterial agents
05/21/2003EP1312347A1 Use of an extract of myrsine africana for the oxidative dyeing of keratinic fibres
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
05/21/2003EP1311497A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
05/21/2003EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311270A1 Non-sedating barbiturate compounds as neuroprotective agents
05/21/2003EP1124805B1 Method for producing 4-[(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols
05/21/2003CN1419549A Method for producing asymmetrical 4,6-bis (aryloxy) pyrimidine derivatives
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1419537A Insecticidal anthranilamides
05/21/2003CN1419452A Synergistic methods and compositions for treating cancer
05/21/2003CN1419450A Nitrite salts of antimicrobial agents
05/21/2003CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph
05/21/2003CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners
05/21/2003CN1109023C Preparation of pyrimiding derivatives
05/21/2003CN1109008C Liquid-crystal alkenyltolan deriv, liquid-crystal composition, and liquid-crystal display element
05/21/2003CN1108796C Use of anticancer material and production method of said anti-cancer material
05/20/2003US6566518 Trifluoromethylpyri(mi)dine carboxamides
05/20/2003US6566409 Lock and key micelles
05/20/2003US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease
05/20/2003US6566380 For therapy of cardiac arrhythmias
05/20/2003US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566330 Positively charged non-natural amino acids, methods of making and using thereof in peptides
05/20/2003US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric
05/20/2003US6565769 Electrooptical liquid crystal system
05/20/2003CA2223016C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
05/20/2003CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
05/20/2003CA2110693C Amino acid derivative anticonvulsant
05/15/2003WO2003040142A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
05/15/2003WO2003040109A2 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040108A1 Quinazoline derivatives as antitumor agents
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003WO2003039549A2 Selective antibacterial agents
05/15/2003WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003WO2003039460A2 Mitotic kinesin inhibitors
05/15/2003WO2002100836A3 Compounds, compositions and methods for modulating beta-amyloid production
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
05/15/2003WO2002026717A8 Hydroxy acid integrin antagonists
05/15/2003WO2002000629A9 Iminopyrimidine nmda nr2b receptor antagonists
05/15/2003US20030092723 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives
05/15/2003US20030092722 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolines useful as HIV reverse transcriptase inhibitors
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092140 Novel polyketides and antibiotics
05/15/2003US20030091946 For color photography; improved image stability
05/15/2003US20030091510 Administering fungicide to mucous membrane
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2465491A1 Mitotic kinesin inhibitors
05/15/2003CA2465100A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2464757A1 Selective antibacterial agents
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1309569A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309568A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309567A2 Nitrogenous heterocyclic compounds
05/14/2003EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
05/14/2003EP1309565A1 Heterocyclic mutilin esters and their use as antibacterials
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP0757678B1 Process for the preparation of 4,6-dichloropyrimidine
05/14/2003CN1418199A Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
05/14/2003CN1418198A Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino] pyrimidin-5-yl]-(3R5S)-3,5-dihydroxyhept-6-enojc acid
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1108293C Substituted 1-amino-3-phenyluracil derivatives, their preparation and their use as herbicides
05/14/2003CN1108288C Benzyloxy substituted aromatics and their use as fungicides
05/13/2003US6562970 Method for producing 4-chloro-6-hydroxypyrimidine
05/13/2003US6562969 Ricin inhibitors and methods for use thereof
05/13/2003US6562833 Treating the fungi or the plants, seeds, material or the soil to be protected against fungal infection with a fungicidally effective amount of at least one 2-(N-phenylamino)pyrimidine
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562827 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages
05/13/2003US6562819 Compounds for inhibition of ceramide-mediated signal transduction
05/13/2003US6562818 Irreversible inhibitors of tyrosine kinases
05/13/2003US6562817 Suppressants of the IgE production
1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 427